Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_assertion type Assertion NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_head.
- NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_assertion description "[These studies show CCR9 is functionally and significantly expressed by BrCa (poorly > moderately differentiated) tissue and cells as well as that CCL25 activation of this receptor promotes breast tumor cell migration, invasion and MMP expression, which are key components of BrCa metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_provenance.
- NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_assertion evidence source_evidence_literature NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_provenance.
- NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_assertion SIO_000772 21344163 NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_provenance.
- NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_assertion wasDerivedFrom befree-20150227 NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_provenance.
- NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_assertion wasGeneratedBy ECO_0000203 NP687027.RAFe3Om7pML06eDvLQLQryodjv4TOlUyLVvsO1J_Sme3Q130_provenance.